Reata Pharmaceuticals has been acquired by Biogen. Please visit www.biogen.com for more information.

Site Search

Search query

About Us
- Leadership
- Ethics & Compliance
Our Science
Diseases We Target
- Neurology
  - Friedreich's Ataxia
  - Diabetic Peripheral Neuropathic Pain
Product
Our Community
Investors
Careers
Contact Us
- Locations

About Us
- Leadership
- Ethics & Compliance
Our Science
Diseases We Target
- Neurology
  - Friedreich's Ataxia
  - Diabetic Peripheral Neuropathic Pain
Product
Our Community
Investors
Careers
Contact Us
- Locations

Twitter opens in a new window
Linkedin opens in a new window
Facebook opens in a new window
Instagram opens in a new window

SEC Filings

About Us
- Leadership
- Ethics & Compliance
Our Science
Diseases We Target
- Neurology
  - Friedreich's Ataxia
  - Diabetic Peripheral Neuropathic Pain
Product
Our Community
Investors
Careers
Contact Us
- Locations

Selecting the value will change the page content

Select year:

Filter filing type:

Date Filing Type Filing Description Download / View

Investor Contact

(855) 55-REATA
IR@reatapharma.com

Contact the Board

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Reata Pharmaceuticals Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Reata Pharmaceuticals Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Mailing Lists *

Press Releases
Events
Presentations
SEC Filings
End of Day Stock Quote
Quarterly Reports
Annual Reports

Email Alert Sign Up Confirmation

Intended for US residents only.

Sitemap
Legal Message
Privacy Notice
Social Media Disclosure
Contact Us

Stay Connected Mobile

Twitter opens in a new window
Linkedin opens in a new window
Facebook opens in a new window
Instagram opens in a new window